183 related articles for article (PubMed ID: 20150254)
1. High-contrast PET of melanoma using (18)F-MEL050, a selective probe for melanin with predominantly renal clearance.
Denoyer D; Greguric I; Roselt P; Neels OC; Aide N; Taylor SR; Katsifis A; Dorow DS; Hicks RJ
J Nucl Med; 2010 Mar; 51(3):441-7. PubMed ID: 20150254
[TBL] [Abstract][Full Text] [Related]
2. [
Rizzo-Padoin N; Chaussard M; Vignal N; Kotula E; Tsoupko-Sitnikov V; Vaz S; Hontonnou F; Liu WQ; Poyet JL; Vidal M; Merlet P; Hosten B; Sarda-Mantel L
Nucl Med Biol; 2016 Dec; 43(12):773-780. PubMed ID: 27693672
[TBL] [Abstract][Full Text] [Related]
3. Improved detection of regional melanoma metastasis using 18F-6-fluoro-N-[2-(diethylamino)ethyl] pyridine-3-carboxamide, a melanin-specific PET probe, by perilesional administration.
Denoyer D; Potdevin T; Roselt P; Neels OC; Kirby L; Greguric I; Katsifis A; Dorow DS; Hicks RJ
J Nucl Med; 2011 Jan; 52(1):115-22. PubMed ID: 21149487
[TBL] [Abstract][Full Text] [Related]
4. Melanin-targeted preclinical PET imaging of melanoma metastasis.
Ren G; Miao Z; Liu H; Jiang L; Limpa-Amara N; Mahmood A; Gambhir SS; Cheng Z
J Nucl Med; 2009 Oct; 50(10):1692-9. PubMed ID: 19759116
[TBL] [Abstract][Full Text] [Related]
5. (123)I-BZA2 as a melanin-targeted radiotracer for the identification of melanoma metastases: results and perspectives of a multicenter phase III clinical trial.
Cachin F; Miot-Noirault E; Gillet B; Isnardi V; Labeille B; Payoux P; Meyer N; Cammilleri S; Gaudy C; Razzouk-Cadet M; Lacour JP; Granel-Brocard F; Tychyj C; Benbouzid F; Grange JD; Baulieu F; Kelly A; Merlin C; Mestas D; Gachon F; Chezal JM; Degoul F; D'Incan M
J Nucl Med; 2014 Jan; 55(1):15-22. PubMed ID: 24263087
[TBL] [Abstract][Full Text] [Related]
6. Detection of melanoma metastases with PET-Comparison of
Wang Y; Li M; Zhang Y; Zhang F; Liu C; Song Y; Zhang Y; Lan X
Nucl Med Biol; 2017 Jul; 50():33-38. PubMed ID: 28433794
[TBL] [Abstract][Full Text] [Related]
7. Discovery of [18F]N-(2-(diethylamino)ethyl)-6-fluoronicotinamide: a melanoma positron emission tomography imaging radiotracer with high tumor to body contrast ratio and rapid renal clearance.
Greguric I; Taylor SR; Denoyer D; Ballantyne P; Berghofer P; Roselt P; Pham TQ; Mattner F; Bourdier T; Neels OC; Dorow DS; Loc'h C; Hicks RJ; Katsifis A
J Med Chem; 2009 Sep; 52(17):5299-302. PubMed ID: 19691348
[TBL] [Abstract][Full Text] [Related]
8. Early detection and longitudinal monitoring of experimental primary and disseminated melanoma using [¹⁰F]ICF01006, a highly promising melanoma PET tracer.
Rbah-Vidal L; Vidal A; Besse S; Cachin F; Bonnet M; Audin L; Askienazy S; Dollé F; Degoul F; Miot-Noirault E; Moins N; Auzeloux P; Chezal JM
Eur J Nucl Med Mol Imaging; 2012 Sep; 39(9):1449-61. PubMed ID: 22707183
[TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of a novel Al(18)F-NOTA-BZA conjugate for melanin-targeted imaging of malignant melanoma.
Chang CC; Chang CH; Lo YH; Lin MH; Shen CC; Liu RS; Wang HE; Chen CL
Bioorg Med Chem Lett; 2016 Aug; 26(16):4133-9. PubMed ID: 27445169
[TBL] [Abstract][Full Text] [Related]
10. Rapid radiosynthesis of two [
Seddik U; Aglan H; Trencsényi G; Szabó JP; Kertész I; Kandil SA
Appl Radiat Isot; 2018 Feb; 132():142-146. PubMed ID: 29227835
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and Preclinical Evaluation of
Xu X; Yuan L; Yin L; Jiang Y; Gai Y; Liu Q; Wang Y; Zhang Y; Lan X
Mol Pharm; 2017 Nov; 14(11):3896-3905. PubMed ID: 29037039
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis imaging probe predicts early chemotherapy response in preclinical models: A comparative study with 18F-FDG PET.
Song S; Xiong C; Lu W; Ku G; Huang G; Li C
J Nucl Med; 2013 Jan; 54(1):104-10. PubMed ID: 23283564
[TBL] [Abstract][Full Text] [Related]
13. Imaging malignant melanoma with (18)F-5-FPN.
Feng H; Xia X; Li C; Song Y; Qin C; Liu Q; Zhang Y; Lan X
Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):113-122. PubMed ID: 26260649
[TBL] [Abstract][Full Text] [Related]
14. Biodistribution, Radiation Dosimetry, and Clinical Application of a Melanin-Targeted PET Probe,
Ma X; Wang S; Wang S; Liu D; Zhao X; Chen H; Kang F; Yang W; Wang J; Cheng Z
J Nucl Med; 2019 Jan; 60(1):16-22. PubMed ID: 29853651
[No Abstract] [Full Text] [Related]
15. Ultrasensitive detection of malignant melanoma using PET molecular imaging probes.
Pyo A; Kim DY; Kim H; Lim D; Kwon SY; Kang SR; Kim HS; Bom HS; Min JJ
Proc Natl Acad Sci U S A; 2020 Jun; 117(23):12991-12999. PubMed ID: 32439710
[TBL] [Abstract][Full Text] [Related]
16. Using dual-tracer PET to predict the biologic behavior of human colorectal cancer.
Wang H; Zhang J; Tian J; Qu B; Li T; Chen Y; Liu J; Wang S
J Nucl Med; 2009 Nov; 50(11):1857-64. PubMed ID: 19837754
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of planar bioluminescence imaging and microPET/CT for therapy monitoring in a mouse model of pigmented metastatic melanoma.
Pasquereau-Kotula E; Hosten B; Hontonnou F; Vignal N; Antoni F; Poyet JL; Rizzo-Padoin N; Sarda-Mantel L
Am J Nucl Med Mol Imaging; 2018; 8(6):397-406. PubMed ID: 30697459
[TBL] [Abstract][Full Text] [Related]
18. [Correlation of 3'-deoxy-3'-18F-fluorothymidine uptake to cell proliferation in lung carcinoma xenografts].
Liu X; Zhou NK; Zhang JM; Liang ZY; Zheng X
Ai Zheng; 2006 Dec; 25(12):1512-6. PubMed ID: 17166377
[TBL] [Abstract][Full Text] [Related]
19.
Pyo A; Kim HS; Kim HS; Yun M; Kim DY; Min JJ
J Nucl Med; 2019 Jul; 60(7):924-929. PubMed ID: 30552204
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
